PEVIANI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 1.422
AS - Asia 869
EU - Europa 793
SA - Sud America 93
AF - Africa 15
Totale 3.192
Nazione #
US - Stati Uniti d'America 1.395
CN - Cina 454
SG - Singapore 201
IE - Irlanda 189
IT - Italia 138
HK - Hong Kong 121
RU - Federazione Russa 115
DE - Germania 79
BR - Brasile 76
FI - Finlandia 75
UA - Ucraina 63
GB - Regno Unito 31
SE - Svezia 30
VN - Vietnam 30
IN - India 20
CA - Canada 19
BE - Belgio 18
PL - Polonia 12
ES - Italia 9
FR - Francia 9
JP - Giappone 9
ZA - Sudafrica 8
AR - Argentina 7
MX - Messico 7
NL - Olanda 7
LT - Lituania 5
AT - Austria 4
CO - Colombia 4
ID - Indonesia 4
IQ - Iraq 4
TR - Turchia 4
DK - Danimarca 3
KR - Corea 3
KZ - Kazakistan 3
MA - Marocco 3
BD - Bangladesh 2
CZ - Repubblica Ceca 2
IR - Iran 2
MY - Malesia 2
PK - Pakistan 2
UZ - Uzbekistan 2
AL - Albania 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EC - Ecuador 1
EG - Egitto 1
GA - Gabon 1
GR - Grecia 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
SA - Arabia Saudita 1
TH - Thailandia 1
VE - Venezuela 1
Totale 3.192
Città #
Dallas 213
Dublin 189
Chandler 175
Hong Kong 121
Beijing 107
San Jose 107
Ashburn 100
Nanjing 100
Singapore 97
Jacksonville 80
Ann Arbor 54
Pavia 54
Boardman 51
Los Angeles 36
Princeton 35
Lawrence 34
Wilmington 31
Helsinki 30
Nanchang 29
New York 28
Munich 27
Medford 23
Moscow 23
Milan 21
Redondo Beach 21
Piscataway 19
Shanghai 19
Hebei 18
Buffalo 16
Changsha 15
Jiaxing 15
Brussels 14
Shenyang 13
São Paulo 13
Tianjin 13
The Dalles 12
Warsaw 12
Chicago 11
Ho Chi Minh City 9
Orem 9
Seattle 9
Woodbridge 9
Denver 8
Tokyo 8
Toronto 8
Turku 8
Johannesburg 7
Rome 7
Stockholm 7
Chongqing 6
Falls Church 6
Hangzhou 6
Washington 6
Columbus 5
Hanoi 5
Montreal 5
Mumbai 5
New Delhi 5
Nuremberg 5
Chennai 4
Des Moines 4
Houston 4
Jinan 4
Manchester 4
Mexico City 4
Phoenix 4
Piemonte 4
Pune 4
Tappahannock 4
Ankara 3
Atlanta 3
Boston 3
Curitiba 3
Fairfield 3
Guangzhou 3
Newark 3
Poplar 3
Qingdao 3
Rio de Janeiro 3
Santa Clara 3
Secaucus 3
Amsterdam 2
Apucarana 2
Auburn Hills 2
Bologna 2
Brooklyn 2
Calusco d'Adda 2
Casorate Primo 2
City of London 2
Dong Ket 2
Falkenstein 2
Handan 2
Jakarta 2
London 2
Medellín 2
Miami 2
Ningbo 2
Norwalk 2
Rabat 2
Reggio Emilia 2
Totale 2.233
Nome #
(R)-RC-33 as Promising Neuroprotective Agent Acting as Sigma1 Receptor Agonist 143
Studies on the Enantiomers of RC-33 as Neuroprotective Agents: Isolation, Configurational Assignment, and Preliminary Biological Profile 135
Chemical, pharmacological, and in vitro metabolic stability studies on enantiomerically pure RC-33 compounds, promising neuroprotective agents acting as sigma1 receptor agonists. 131
Essential Amino Acid Supplementation May Attenuate Systemic Inflammation and Improve Hypoalbuminemia in Subacute Hemiplegic Stroke Patients 130
A step forward in the sigma enigma: a role for chirality in the sigma1 receptor- ligand interaction? 127
Identification of RC-33 as a potent and selective sigma1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. Part 2: g-scale synthesis, physicochemical characterization and in vitro metabolic stability. 126
Identification of a potent and selective sigma1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. 114
Development of easy-to-use reverse-phase liquid chromatographic methods for determining PRE-084, RC-33 and RC-34 in biological matrices. The first step for in vivo analysis of sigma1 receptor agonists. 104
Accumulation of human SOD1 and ubiquitinated deposits in the spinal cord of SOD1G93A mice during motor neuron disease progression correlates with a decrease of proteasome. 102
In Situ Agar – Carbomer Hydrogel Polycondensation:a Chemical Approach to Regenerative Medicine 99
COMPOSITIONS AND METHODS FOR TARGETING CELLS 99
COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS OF THE CENTRAL NERVOUS SYSTEM 96
Differences in protein quality control correlate with phenotype variability in 2 mouse models of familial amyotrophic lateral sclerosis 94
Inter- and intracellular signaling in amyotrophic lateral sclerosis: role of p38 mitogen-activated protein kinase. 86
Bitopic Sigma 1 Receptor Modulators to Shed Light on Molecular Mechanisms Underpinning Ligand Binding and Receptor Oligomerization 86
Heterogeneity of neuroinflammatory responses in amyotrophic lateral sclerosis: A challenge or an opportunity? 82
Hydrazone linked doxorubicin-PLA prodrug nanoparticles with high drug loading 79
Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084,in a mouse model of motor neuron disease not linked to SOD1 mutation 77
Chemical, pharmacological and in vivo pharmacokinetic studies on enantiomerically pure RC-33 compounds, promising neuroprotective agents acting as sigma1 receptor agonists 75
Fast deep learning reconstruction techniques for preclinical magnetic resonance fingerprinting 71
Studies on the enantiomers of RC-33, promising neuroprotective agents acting as sigma1 receptor agonists. Isolation, configurational assignment and biological profile 71
Unraveling the complexity of amyotrophic lateral sclerosis: recent advances from the transgenic mutant SOD1 mice. 70
Use of arylalkanolamines as sigma-1 receptor antagonists 70
Lack of changes in the PI3K/AKT survival pathway in the spinal cord motor neurons of a mouse model of familial amyotrophic lateral sclerosis. 69
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 67
Delivery Platforms for CRISPR/Cas9 Genome Editing of Glial Cells in the Central Nervous System 64
Sigma1 Receptor Agonists in motor dysfunction pathologies treatment – a medicinal chemistry perspective 63
Discovery of RC-752, a Novel Sigma-1 Receptor Antagonist with Antinociceptive Activity: A Promising Tool for Fighting Neuropathic Pain 61
Neurophysiological characterisation of the g93a ALS rat model 61
Synthesis and characterization of a “clickable” pbr28 tspo-selective ligand derivative suitable for the functionalization of biodegradable polymer nanoparticles 55
Intracerebroventricular delivery of hematopoietic progenitors results in rapid and robust engraftment of microglia-like cells 54
Biodegradable polymeric nanoparticles administered in the cerebrospinal fluid: Brain biodistribution, preferential internalization in microglia and implications for cell-selective drug release 51
Lentiviral vectors carrying enhancer elements of Hb9 promoter drive selective transgene expression in mouse spinal cord motor neurons. 50
Lipophilic dye-compatible brain clearing technique allowing correlative magnetic resonance/high-resolution fluorescence imaging in rat models of glioblastoma 49
Haploinsufficiency at the CX3CR1 locus of hematopoietic stem cells favors the appearance of microglia-like cells in the central nervous system of transplant recipients 48
Novel S1R agonists counteracting NMDA excitotoxicity and oxidative stress: A step forward in the discovery of neuroprotective agents 46
Metallothioneins are neuroprotective agents in lysosomal storage disorders 44
T1-weighted dynamic contrast-enhanced MRI is a noninvasive marker of epidermal growth factor receptor VIII status in cancer stem cell-derived experimental glioblastomas 44
Therapeutic efficacy of intracerebral hematopoietic stem cell gene therapy in an Alzheimer's disease mouse model 40
An innovative hematopoietic stem cell gene therapy approach benefits CLN1 disease in the mouse model 39
Simultaneous flow cytometric characterization of multiple cell types retrieved from mouse brain/spinal cord through different homogenization methods 38
Effect of Lipid Nanoparticle Physico-Chemical Properties and Composition on Their Interaction with the Immune System 35
null 9
Totale 3.254
Categoria #
all - tutte 14.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.124


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202199 0 0 0 0 0 0 1 41 17 18 16 6
2021/2022173 7 2 8 3 5 7 7 15 16 6 18 79
2022/2023529 56 54 1 33 43 58 0 29 231 2 12 10
2023/2024230 27 30 7 10 22 59 5 18 2 10 36 4
2024/2025651 20 44 13 18 23 72 35 34 159 26 68 139
2025/20261.036 112 78 283 171 182 70 140 0 0 0 0 0
Totale 3.254